Hold JPM at ~3.5% with active architecture: reject adds into resistance/catalyst, keep $315-320 floor support with tail hedges, pre-commit Q3 earnings scenarios, enforce -2% relative-to-SPY reassessment
JPM fundamentals (17.79% ROE, $33B+ buyback, $45B+ capital return, $5T asset base, structural NIM tailwind from 96-97% Polymarket no-cut probability) are genuinely best-in-class and explain why the rising 200 SMA at $319.98 has historically been a launching pad, not a breakdown level. However, momentum is broken (50 SMA breakdown, expanding negative MACD histogram at -1.83, RSI ~35 with no bullish divergence, distribution day running 40-100% above normal volume) and the path asymmetry favors the downside: reaching $366 requires clearing four resistance layers ($340 10 EMA, $345, $352.89 50 SMA, $353 prior breakdown zone) while the path to $300/$285 requires nothing. The Aggressive analyst's structural re-rating argument fights the wrong battle — Shiller CAPE above 40 means the broader market will not underwrite premium multiples if equities correct. A 4% position with stop at $318 going into Oct 13 earnings is a leveraged bet on a binary catalyst where gap-down risk through the stop is real because bank stocks routinely move 5-8% on guidance-driven repricing. The synthesis is Hold at benchmark weight with executable discipline: maintain franchise exposure, refuse to add into four layers of overhead resistance with broken momentum and imminent Q3 risk, use closing-basis stops not wick stops, keep cheap tail protection, pre-commit earnings scenarios, and enforce -2% relative-to-SPY reassessment so passive Hold does not bleed alpha into the catalyst.
| Position | Action |
|---|---|
| No adds below $345 into four stacked resistance layers with broken momentum into Q3 catalyst | Maintain benchmark weight ~3.5%, no new longs |
| Daily close above $345 on above-average volume with RSI >45 and MACD histogram contracting | Add 2% position (Tier 1 upgrade) |
| Daily close above $352.89 (50 SMA reclaim) with RSI >55 and positive MACD histogram cross | Add 2-3% position and re-rate to Overweight (Tier 2 upgrade) |
| Price tags $315-320 zone and closes back above $322 with rising volume (2-day hold above 200 SMA confirms support) | Add 1/3 of target weight with closing-basis stop at $319.98 (hard floor tactical add) |
| Sustained close below $319.98 on above-average volume with 2-3 session hold (NOT single wick) | Trim 15-20% of position and re-rate to Underweight |
| Price rallies to $338-340 zone (10 EMA confluence) | Trim into strength, not weakness — sell zones are distribution opportunities, not chase points |
| Price rallies to $346-349 zone (Bollinger Middle / 50 SMA retest) | Trim into strength if currently overweight |
| Pre-committed: Q3 EPS ≥$6.50 with NII guide reaffirmed and stable deposit/provisioning commentary | Add 25% on next pullback to 10 EMA, re-rate to Overweight |
The pullback to ~$333 near the rising 200 SMA ($320.07) is a bull flag, not a breakdown; with Q2 2026 earnings accelerating (Revenue +17.7% YoY, NII +9.9% YoY for 5 straight quarters, record EPS of $7.70) and 5.9% annual capital return supporting EPS growth, JPM offers a high-probability setup to reach $1T market cap.
| Indicator | Value | Signal |
|---|---|---|
| Close | 333.18 | neutral |
| 10 EMA | 338.90 | bearish |
| 50 SMA | 352.59 | bearish |
| 200 SMA | 320.07 | bullish |
| RSI | 35.15 | neutral |
| MACD Line | -5.36 | bearish |
| MACD Signal | -3.54 | bearish |
| MACD Histogram | -1.83 | bearish |
| ATR (14-day) | 6.58 | neutral |
| Bollinger Middle Band | 346.80 | neutral |
| Bollinger Lower Band | 328.43 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
| Pre-committed: Q3 EPS $6.00-6.50 with flat-to-positive NII and elevated but stable charges | Maintain Hold, no position change |
| Pre-committed: Q3 EPS <$6.00 OR NII guide weakens OR material CRE/provisioning acceleration OR deposit migration disclosure | Exit 50-75% of position regardless of price action, downgrade to Underweight |
| No collar hedge (per 9/25 binding lesson — strikes within ~12% of spot cap recovery while premium bleed turns active Hold into structural alpha drag) | No collar hedge |
Technical setup is a bull flag near rising 200 SMA support, not a breakdown
↩ rebuts: “Bear reading of 50 SMA breakdown as trend change”
EV: +20%+ to $400+ (T3) · concedes: Investment banking fees could disappoint in hawkish macro environment; Current P/E of 14.3x is not cheap on an absolute basis; Short-term stock is below all short-term moving averages (10 EMA, 50 SMA)
JPM is a falling knife at $333: the Q2 earnings beat is artificially inflated by a one-time $4.4B gain masking flat sequential earnings, NII growth is decelerating, technical momentum is expanding negatively, the 200 SMA at $320 is likely to break, and the Polymarket's 22% probability on $1T is rational, not pessimistic.
· concedes: Beat on EPS is likely (82% probability); Buybacks are ongoing and EPS-accretive; ROE at 17.79% remains excellent by industry standards
→ vs conservative: MACD at -1.83, 50 SMA breakdown, and September 22 distribution day are lagging indicators in a secular uptrend; the 0.4% of float distribution is noise not capitulation (capitulation would be 2-3% of float)
→ vs conservative: Waiting for 200 SMA retest at 320 risks missing the entire move if JPM bounces hard off 333 on Q3 print and rips to 360; if price does tag 320, something would have broken structurally making it a falling knife
→ vs conservative: The $4.4 billion unusual item masks 17.78 billion normalized income up 18% year-over-year, which is elite not flat; Dimon's platform generates special situations gains as a feature of scale
→ vs neutral: Silence before JPM earnings is not uncertainty but a coiled spring consistent with pre-earnings blackout; smart money doesn't telegraph moves on Reddit
→ vs conservative: Adding above 335 fights the tape framing is overly cautious for a 17.79% ROE name at fair value with a known catalyst in 12 trading days
| neutral |
Support: 328.43 · 325.87 · 320.07 · 319.83 · 318.48 | Resistance: 338.9 · 346.8 · 352.59
JPM technical analysis shows a short-term correction within a long-term uptrend. Short-term momentum is bearish with price below the 10 EMA (338.90) and 50 SMA (352.59), while the 200 SMA (320.07) remains intact and rising. MACD is bearish and expanding at -5.36 with histogram at -1.83, RSI is weak at 35.15 above oversold, and ATR of 6.58 indicates moderate volatility. Key support zones are 328.43 (Bollinger lower), 325.87 (recent intraday low), and 320.07 (200 SMA); resistance sits at 338.90, 346.80, and 352.59. The report recommends HOLD.
Market Cap
$885,654,487,040
Total Assets
$5,015B
Total Equity
$374.6B
Common Stockholders' Equity
$354B
Tangible Book Value
$289.3B
Net Loans
$1,516B
Investments & Advances
$1,587B
Cash & Equivalents
$310B
Total Debt
$533B
Revenue (Q2'26)
$52.85B
Revenue (Q1'26)
$49.83B
Revenue (Q4'25)
$45.80B
Revenue (Q3'25)
$46.43B
Revenue (Q2'25)
$44.88B
Net Interest Income (Q2'26)
$25.51B
Net Interest Income (Q1'26)
$25.37B
Net Interest Income (Q4'25)
$25.00B
Net Interest Income (Q3'25)
$23.97B
Net Interest Income (Q2'25)
$23.21B
Pretax Income (Q2'26)
$27.52B
Pretax Income (Q1'26)
$20.48B
Pretax Income (Q4'25)
$17.16B
Pretax Income (Q3'25)
$18.74B
Pretax Income (Q2'25)
$18.28B
Net Income (Q2'26)
$21.16B
Net Income (Q1'26)
$16.49B
Net Income (Q4'25)
$13.03B
Net Income (Q3'25)
$14.39B
Net Income (Q2'25)
$14.99B
Diluted EPS (Q2'26)
$7.70
Diluted EPS (Q1'26)
$5.94
Diluted EPS (Q4'25)
$4.63
Diluted EPS (Q3'25)
$5.07
Diluted EPS (Q2'25)
$5.24
EPS (TTM)
$23.32
Forward EPS
$25.05
Profit Margin
34.92%
Operating Margin
50.39%
Return on Equity (ROE)
17.79%
Return on Assets (ROA)
1.36%
P/E (TTM)
14.29x
Forward P/E
13.30x
P/B
2.50x
PEG
1.55
Dividend Yield
1.99%
Beta
0.975
52-Week Range
$279.10 – $366.50
50-Day Moving Average
$352.89
200-Day Moving Average
$321.63
Implied Price
~$329
Unusual Items (Q2'26)
~$4.39B
Normalized Net Income (Q2'26)
~$17.78B
Buybacks (Q2'26)
$8.79B
Buybacks (Q1'26)
$8.33B
Buybacks (Q4'25)
$8.26B
Buybacks (Q3'25)
$8.29B
Buybacks (Q2'25)
$7.51B
Dividends Paid (Q2'26)
$4.34B
Dividends Paid (Q1'26)
$4.37B
Dividends Paid (Q4'25)
$4.42B
Dividends Paid (Q3'25)
$4.18B
Dividends Paid (Q2'25)
$4.21B
Total Capital Return (Q2'26)
$13.13B
Total Capital Return (Q1'26)
$12.70B
Total Capital Return (Q4'25)
$12.68B
Total Capital Return (Q3'25)
$12.47B
Total Capital Return (Q2'25)
$11.72B
Share Count (Q2'26)
~2.658B
Share Count (Q2'25)
~2.750B
Net Debt
$223B
Dividend Coverage Ratio
~3.7x
Trading Securities
$794B
Preferred Issuance (Q2'26)
$3B
Debt Issuance (Q1'26)
$49.9B
Operating CF (Q2'26)
-$25.3B
Operating CF (Q1'26)
-$211.8B
Operating CF (Q4'25)
+$119.7B
Operating CF (Q2'25)
+$29.5B
Upside to 52-Week High
~11.4%
Upside to 50-Day MA Reversion
~7.1%
Strengths
Concerns
JPM delivered exceptional Q2'26 results with record revenue of $52.85B (+17.7% YoY) and all-time high EPS of $7.70, powered by industry-leading 17.79% ROE and 50.39% operating margin from its $5.02T balance sheet; however, net income of $21.16B included ~$4.39B of one-time gains, and the stock trades near mid-range of its 52-week range ($279.10-$366.50) with resistance at the 50-day MA of $352.89. The bank is executing an aggressive capital return program of ~$52B annually (5.9% of market cap) while reducing share count by 3.3% YoY, though valuation at 14.29x P/E appears fair rather than compelling. The risk-reward favors accumulation on weakness toward the 200-day MA (~$321), with momentum confirmation needed on a break above $353 to resume the uptrend toward the 52-week high of $366.50.
Macro: A hawkish-Fed, high-yield regime (10Y highest since 2002, biggest monthly gain since 2022) structurally supports JPM's net interest income but compresses capital-markets activity and equity multiples. US recession odds for 2026 are 8% (down 2pp WoW), suggesting a low tail-risk premium and benign credit narrative.